Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
One World ProductsOWPC 3-Year EBITDA Growth Rate is 20.10% as of Sep. 2025, which is 179% above its 10-year median of 7.20. The stock has 4 warning signs investors should review. Among 813 Drug Manufacturers companies, One World Products ranks better than 68.27% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 20.10% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 29.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of One World Products was 36.00% per year. The lowest was -71.40% per year. And the median was 7.20% per year.
One World Products (OTCPK:OWPC) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
One World Products 3-Year EBITDA Growth Rate Related Terms
OWPC vs CBSTQ, PTPI, KOAN: 3-Year EBITDA Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, One World Products's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
One World Products 3-Year EBITDA Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, One World Products's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where One World Products's 3-Year EBITDA Growth Rate falls into.
One World Products 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 20.10% mean?
One World Products (OWPC) has a 3-Year EBITDA Growth Rate of 20.10% as of Sep. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for One World Products and its competitors. This is 179% above median its historical median of 7.20. According to the industry distribution chart, One World Products ranks #258 out of 813 companies in the Drug Manufacturers industry, placing it in the top 31.7%.
Is One World Products' 3-Year EBITDA Growth Rate too high?
One World Products' current 3-Year EBITDA Growth Rate of 20.10% is 179% above median its 10-year median of 7.20. The Drug Manufacturers industry median 3-Year EBITDA Growth Rate is 8.80. One World Products' value of 20.10% is 128.4% above this industry median. Based on the distribution chart, One World Products ranks #258 out of 813 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does One World Products' 3-Year EBITDA Growth Rate compare to CBSTQ and PTPI?
According to the Drug Manufacturers industry distribution chart, One World Products ranks #258 out of 813 companies for 3-Year EBITDA Growth Rate. This puts One World Products in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 8.80. One World Products' value of 20.10% is 128.4% above this benchmark. While the company's 10-year median is 7.20 vs. the industry median of 8.80, One World Products has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Drug Manufacturers company?
The median 3-Year EBITDA Growth Rate among Drug Manufacturers companies is 8.80, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. One World Products's current 3-Year EBITDA Growth Rate of 20.10% is 128.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for One World Products and its competitors. For the Drug Manufacturers industry, the median 3-Year EBITDA Growth Rate is 8.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. One World Products's current 3-Year EBITDA Growth Rate is 20.10%, which is 179% above median its own 10-year median of 7.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is One World Products stock overvalued right now?
One World Products (OWPC) has a current 3-Year EBITDA Growth Rate of 20.10%. The current 3-Year EBITDA Growth Rate is 20.10%, which is 179% above median its 10-year median of 7.20 and 128.4% above the Drug Manufacturers industry median of 8.80. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For One World Products (OWPC), the current 3-Year EBITDA Growth Rate is 20.10% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
One World Products Inc along with its subsidiaries is engaged in the cultivation, production, and distribution of raw cannabis and hemp plant ingredients for both medical and industrial uses. It focuses on cultivating, processing, and supplying cannabis oil, distillate, and isolate to customer's specifications. The Company operates as a single segment, consisting of its CBD sales operations in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OWPC has been successfully added to your 
